Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / SNTI - Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? | Benzinga

SNTI - Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? | Benzinga

Senti Biosciences Inc.

Senti Biosciences Inc (NASDAQ:SNTI) shares are trading higher by 102.6% to $0.56 during Monday’s session after the company was awarded $8 million from the California Institute for Regenerative Medicines, which will support the ongoing development of SENTI-202.

The company says SENTI-202 is an investigational cell therapy for treating relapsed/refractory hematologic malignancies, including acute myeloid leukemia (AML). The ongoing Phase 1 trial aims to provide initial efficacy data by the end of 2024 and durability data in 2025.

Timothy Lu, CEO and Co-Founder of Senti Bio, expressed gratitude for CIRM’s support, highlighting SENTI-202’s potential to improve AML treatment. The trial, enrolling adult patients with specific hematologic malignancies in the US and Australia, evaluates two dose levels of SENTI-202 cells administered in cycles after disease-specific ...

SNTI) Stock Is Up Over 100%: What's Happening?>Full story available on Benzinga.com
Stock Information
Company Name: Senti Biosciences Inc.
Stock Symbol: SNTI
Market: NASDAQ
Website: sentibio.com
Menu
SNTI SNTI Quote SNTI Short SNTI News SNTI Articles SNTI Message Board
Get SNTI Alerts

News, Short Squeeze, Breakout and More Instantly...